Literature DB >> 11951174

The effect of attentional dysfunction in Alzheimer's disease: theoretical and practical implications.

Nancy S Foldi1, Jacqueline J Lobosco, Lynn A Schaefer.   

Abstract

Attention may be one of the earliest cognitive abilities to change in Alzheimer's disease (AD), although its role has received belated recognition. This article discusses different aspects of attention and how these are differentially affected in AD. Of the various attention functions, divided and selective attention are particularly vulnerable. The etiology of attentional deficits in AD arises from damage to areas of frontal and parietal association cortex, disconnection between the anterior and posterior attentional networks, and decreased cholinergic function. Severity of illness is associated with attentional deterioration. Complexity or increased load of a task may further disrupt attentional function. Knowledge of attentional changes in AD is important to the understanding of disease-related changes in other cognitive domains such as memory, visuospatial functions, and language.

Entities:  

Mesh:

Year:  2002        PMID: 11951174     DOI: 10.1055/s-2002-24990

Source DB:  PubMed          Journal:  Semin Speech Lang        ISSN: 0734-0478            Impact factor:   1.761


  12 in total

Review 1.  Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review.

Authors:  Michal Harciarek; Krzysztof Jodzio
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

Review 2.  A biased competition account of attention and memory in Alzheimer's disease.

Authors:  Kathrin Finke; Nicholas Myers; Peter Bublak; Christian Sorg
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-09-09       Impact factor: 6.237

Review 3.  Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia.

Authors:  A Shepherd; S Tyebji; A J Hannan; E L Burrows
Journal:  J Mol Neurosci       Date:  2016-09-16       Impact factor: 3.444

4.  Neuropsychological and neuropsychiatric prediction of global cognitive status among older Spanish-speaking Hispanics and English-speaking whites.

Authors:  Elizabeth Guerrero-Berroa; Alan Kluger; James Schmeidler; Kevin Sailor; Humberto Lizardi; James Golomb; Steven Ferris; Barry Reisberg
Journal:  J Geriatr Psychiatry Neurol       Date:  2014-04-22       Impact factor: 2.680

5.  Cerebral metabolic correlates of four dementia scales in Alzheimer's disease.

Authors:  E Salmon; S Lespagnard; P Marique; F Peeters; K Herholz; D Perani; V Holthoff; E Kalbe; D Anchisi; S Adam; F Collette; G Garraux
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

6.  PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.

Authors:  Ahmadul Kadir; Ove Almkvist; Anders Wall; Bengt Långström; Agneta Nordberg
Journal:  Psychopharmacology (Berl)       Date:  2006-07-11       Impact factor: 4.530

7.  Now you make false memories; now you do not: the order of presentation of words in DRM lists influences the production of the critical lure in Alzheimer's disease.

Authors:  Christelle Evrard; Anne-Laure Gilet; Fabienne Colombel; Elodie Dufermont; Yves Corson
Journal:  Psychol Res       Date:  2016-12-03

8.  The MMSE orientation for time domain is a strong predictor of subsequent cognitive decline in the elderly.

Authors:  Elizabeth Guerrero-Berroa; Xiaodong Luo; James Schmeidler; Michael A Rapp; Karen Dahlman; Hillel T Grossman; Vahram Haroutunian; Michal Schnaider Beeri
Journal:  Int J Geriatr Psychiatry       Date:  2009-12       Impact factor: 3.485

Review 9.  The role of higher-level cognitive function in gait: executive dysfunction contributes to fall risk in Alzheimer's disease.

Authors:  Pamela L Sheridan; Jeffrey M Hausdorff
Journal:  Dement Geriatr Cogn Disord       Date:  2007-07-04       Impact factor: 2.959

10.  Attention Measures of Accuracy, Variability, and Fatigue Detect Early Response to Donepezil in Alzheimer's Disease: A Randomized, Double-blind, Placebo-Controlled Pilot Trial.

Authors:  Clara Vila-Castelar; Jenny J Ly; Lillian Kaplan; Kathleen Van Dyk; Jeffrey T Berger; Lucy O Macina; Jennifer L Stewart; Nancy S Foldi
Journal:  Arch Clin Neuropsychol       Date:  2019-05-01       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.